Cambria Cannabis ETF

Trump to Sign Rescheduling Order for Cannabis, Boosting Related Stocks

SNDL Inc. to Acquire 32 Cannabis Stores in Canada

Cronos Group Inc. Acquires Dutch Largest Cannabis Company CanAdelaar B.V. for $67 Million

Village Farms released FY2025 9 Months Earnings on November 10 Pre-Market (EST), actual revenue USD 166.32 M, actual EPS USD 0.2489

Village Farms released FY2025 Q3 earnings on November 10 Pre-Market EST, actual revenue USD 66.74 M (forecast USD 58.63 M), actual EPS USD 0.0777 (forecast USD 0.025)

Turning Point Brands Reports Earnings Per Share Of $1.27, Exceeding Expectations

WM Tech released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 42.18 M (forecast USD 42 M), actual EPS USD 0.02 (forecast USD 0.04)

WM Tech released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 131.64 M and EPS of USD 0.0458

Cronos released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 36.34M (forecast USD 36.86M), actual EPS USD 0.07 (forecast USD 0)

Cronos released FY2025 9 Months Earnings on November 6 Pre-Market EST, actual revenue USD 102.06 M, actual EPS USD -0.0193

Turning Point Brands released FY2025 Q3 earnings on November 5 Pre-Market (EST), actual revenue USD 118.98 M (forecast USD 110.25 M), actual EPS USD 1.1299 (forecast USD 0.695)

Turning Point Brands released FY2025 9 Months Earnings on November 5 Pre-Market EST, with actual revenue of USD 342.05 M and EPS of USD 2.7099

SNDL released FY2025 9 Months earnings on November 4 Pre-Market EST, actual revenue USD 497.22 M, actual EPS USD -0.0686

SNDL released FY2025 Q3 earnings on November 4 Pre-Market (EST), actual revenue USD 175.43 M (forecast USD 174.54 M), actual EPS USD -0.0359 (forecast USD 0)

Village Farms to Release FY2025 Q3 Earnings on November 10 Pre-Market EST, Forecast Revenue USD 58.63 M, EPS USD 0.025

Cronos to Release FY2025 Q3 Earnings on November 6, Pre-Market EST, Forecast Revenue USD 37.34M, EPS USD 0

WM Tech to release FY2025 Q3 earnings on November 6 After-Market EST, forecast revenue USD 42 M, EPS USD 0.04

Turning Point Brands to release FY2025 Q3 earnings on November 5, pre-market EST, with forecast revenue of USD 110.24 M and EPS of USD 0.695

SNDL to Release FY2025 Q3 Earnings on November 4, Pre-Market EST; Forecast Revenue USD 176.26 M, EPS USD 0

Village Farms to Release Q3 2025 Financial Results

Luminar Tech

Novabay Pharmac

Mint Incorporation

Autozi Internet Tech Global

GD Culture

Impact BioMedical

Tradr 2X Long FLY Daily ETF

Leverage Shares 2X Long CRWV Daily ETF

T-REX 2X Long CRWV Daily Target ETF

Wheat Slipping Back to Kick off Friday

Barchart Option

Wheat Slipping Back to Kick off Friday

CRON

TLRY

Cannabis stocks like CGC, TLRY, and CRON surged after President Trump signed an executive order reclassifying cannabis as a Schedule III drug, easing restrictions but not legalizing recreational use. The reclassification aims to facilitate research on cannabis's medical benefits. Despite the stock rise, the AdvisorShares cannabis ETF has dropped over 85% since 2021. Tilray stock has a Moderate Buy rating with a price target suggesting a 44.75% downside.

Tip Ranks

Canopy Growth

Cronos

Tilray Brands

CGC, TLRY, CRON: Cannabis Stocks Soar as Trump Reclassifies the Drug

Cocoa Prices Settle Lower on Expectations of Adequate Supplies

Cocoa Prices Settle Lower on Expectations of Adequate Supplies

Wheat Starting Thursday with Strength

Wheat Starting Thursday with Strength

Cannabis stocks are rallying as U.S. President Trump is expected to announce an executive order easing restrictions on marijuana, potentially reclassifying it from a Schedule I narcotic. This move could dismantle existing drug policies, reduce criminal penalties, and improve industry access to capital. Shares of major cannabis companies like Cronos Group, Aurora Cannabis, Tilray Brands, and Canopy Growth have seen significant premarket increases.

- U.S. listed shares of cannabis companies have increased in anticipation of President Trump’s potential executive order to ease restrictions on marijuana, classifying it as a less dangerous drug.  
- Shares of Cronos Group and Aurora Cannabis rose 4.3% and 4.5% premarket, while Tilray Brands and Canopy Growth jumped 2.8% and 10.4%, respectively.  
- This decision could significantly impact the cannabis industry by potentially dismantling existing drug policies, reducing criminal penalties, and improving access to capital.

Reuters

Aurora Cannabis

BUZZ-Cannabis stocks rally on expectations of Trump move to ease curbs

In Dublin, the "Black Rice Market - Global Forecast 2025-2032" report has been included in ResearchAndMarkets.com's offerings. The black rice market is increasingly important in global nutrition and specialized ingredient strategies. With organizations focusing more on health-oriented products and sustainable sourcing, it is crucial for senior decision-makers to comprehend the competitive dynamics and innovation landscape of this market for building strong value chains and seizing growth opportunities.

Unusual Whales

Black Rice Market to Grow by $8 Billion globally from 2025-2032, becoming essential for nutrition and sustainable sourcing. Resilient value chains critical.

The global rice market is projected to grow by $64 billion from 2025-2032, driven by a shift towards premium and fortified rice products due to health-conscious consumers and government initiatives, according to a report by ResearchAndMarkets.com.

Global rice market to grow by $64 billion from 2025-2032 due to shift towards premium and fortified rice products driven by health-conscious consumers and government initiatives. -ResearchAndMarkets.com

U.S. listed cannabis stocks rise after a CNN report that President Trump may sign an executive order easing restrictions on marijuana, reclassifying it as less dangerous. This could reduce criminal penalties and reshape the industry. Shares of Cronos Group, Aurora Cannabis, Tilray Brands, and Canopy Growth saw significant premarket gains.

- U.S. shares of cannabis companies increased following a CNN report that President Donald Trump will sign an executive order to ease restrictions on marijuana, potentially reclassifying it as a less dangerous substance.  
- Currently classified as a Schedule I narcotic by federal law, marijuana is viewed alongside drugs with no accepted medical use, despite legalization in some states.  
- A reclassification may lower tax burdens and simplify funding access, positively impacting companies such as Cronos Group, Aurora Cannabis, Tilray Brands, and Canopy Growth.

BUZZ-Cannabis stocks rise on report saying Trump may ease restrictions this week

Tilray's stock surged 44.1% as reports suggested President Trump might reclassify marijuana as a Schedule III drug, easing banking restrictions and potentially leading to further legalization. This reclassification could allow larger banks to engage with cannabis businesses, boosting the industry. Other cannabis stocks, like Canopy Growth and Cronos Group, also saw significant gains. However, the White House has not confirmed any decision, and past investor optimism has sometimes been premature.

Dow Jones

Tilray's stock takes off on hope that cannabis will soon be seen as more like steroids than heroin

RIVN

LULU

IIPR

VERA

IBRX

Canopy Growth(CGC) rose 53.98%, with a trading turnover 249.9 Million USD, and a year-to-date fell 36.5%. Tilray Brands(TLRY) rose 44.13%, with a trading turnover 914.6 Million USD, and a year-to-date fell 8.6%. Cronos(CRON) rose 14.74%, with a trading turnover 53.6 Million USD, and a year-to-date rose 61.9%.

Top Gainers & Losers

Clear Secure

Rivian Automotive

Lululemon

Quanex Building Products

Innovative Industrial Properties

Vera Therapeutics

ImmunityBio

Top 10 US Stock Gainers (12.12)

President Trump reportedly plans to advocate for reclassifying marijuana as a Schedule III substance, easing federal regulations. This move could impact the cannabis industry by expanding research access and increasing profits for licensed businesses. The reclassification would not legalize or decriminalize marijuana but signals a major shift in cannabis policy. Despite regulatory challenges, cannabis stocks like Tilray and Cronos have shown improvement. Trump's potential endorsement is seen as a significant change in policy by industry leaders.

benzinga_article

Trump Reportedly Plans Major Shift To Ease Federal Marijuana Rules

U.S.-listed cannabis stocks surged after reports that President Trump may ease federal marijuana restrictions, potentially reclassifying it from Schedule I to Schedule III. Canopy Growth, Cronos Group, Tilray Brands, SNDL, and Aurora Cannabis saw significant gains, along with cannabis ETFs AdvisorShares Pure US Cannabis and Roundhill Cannabis.

- U.S.-listed shares of cannabis firms surged in premarket trading following reports that President Donald Trump plans to ease federal restrictions on marijuana.  
- Trump discussed the potential reclassification of marijuana from a Schedule I to a Schedule III substance with House Speaker Mike Johnson, which could significantly impact the cannabis industry.  
- Notable stock increases included Canopy Growth rising 18.1%, Cronos Group up 11.9%, and Tilray Brands climbing 28.4%, alongside substantial gains in cannabis ETFs.

BUZZ-Pot stocks climb on report Trump considers easing marijuana restrictions

Shares of Cronos Group Inc. (CRON) rose 2.15% to $2.85 on Thursday, outperforming the market in a mixed trading session. This marks the stock's third consecutive day of gains. The stock is 9.81% below its 52-week high of $3.16. Trading volume was 2.6 million, above the 50-day average of 1.8 million.

Cronos Group Inc. Stock Rises Thursday, Outperforms Market

GTBIF

2026 could be pivotal for cannabis reform in the U.S. and Europe, with potential benefits for companies like Green Thumb Industries and Cronos. U.S. midterms may drive reform, with rescheduling boosting cash flow. Green Thumb is noted for its strong balance sheet and share buybacks. In Europe, Cronos is expanding, leveraging its financial strength and strategic flexibility. Both companies are positioned to capitalize on market changes.

CabotWealthNetwork

Green Thumb Industries Inc.

2026 Could Be a Big Year for Cannabis Reform